- South Korea
- /
- Personal Products
- /
- KOSE:A090430
Estimating The Fair Value Of Amorepacific Corporation (KRX:090430)
Key Insights
- Amorepacific's estimated fair value is ₩185,111 based on 2 Stage Free Cash Flow to Equity
- Amorepacific's ₩149,900 share price indicates it is trading at similar levels as its fair value estimate
- Our fair value estimate is 4.9% lower than Amorepacific's analyst price target of ₩194,750
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Amorepacific Corporation (KRX:090430) as an investment opportunity by taking the expected future cash flows and discounting them to their present value. This will be done using the Discounted Cash Flow (DCF) model. Models like these may appear beyond the comprehension of a lay person, but they're fairly easy to follow.
We would caution that there are many ways of valuing a company and, like the DCF, each technique has advantages and disadvantages in certain scenarios. If you want to learn more about discounted cash flow, the rationale behind this calculation can be read in detail in the Simply Wall St analysis model.
See our latest analysis for Amorepacific
The Model
We're using the 2-stage growth model, which simply means we take in account two stages of company's growth. In the initial period the company may have a higher growth rate and the second stage is usually assumed to have a stable growth rate. In the first stage we need to estimate the cash flows to the business over the next ten years. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.
A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, so we discount the value of these future cash flows to their estimated value in today's dollars:
10-year free cash flow (FCF) forecast
2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | |
Levered FCF (₩, Millions) | ₩482.7b | ₩540.3b | ₩583.7b | ₩621.0b | ₩653.5b | ₩682.5b | ₩708.9b | ₩733.6b | ₩757.1b | ₩779.9b |
Growth Rate Estimate Source | Analyst x9 | Analyst x8 | Est @ 8.03% | Est @ 6.39% | Est @ 5.24% | Est @ 4.44% | Est @ 3.87% | Est @ 3.48% | Est @ 3.20% | Est @ 3.01% |
Present Value (₩, Millions) Discounted @ 7.3% | ₩449.9k | ₩469.4k | ₩472.6k | ₩468.6k | ₩459.6k | ₩447.4k | ₩433.1k | ₩417.7k | ₩401.8k | ₩385.8k |
("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = ₩4.4t
After calculating the present value of future cash flows in the initial 10-year period, we need to calculate the Terminal Value, which accounts for all future cash flows beyond the first stage. For a number of reasons a very conservative growth rate is used that cannot exceed that of a country's GDP growth. In this case we have used the 5-year average of the 10-year government bond yield (2.6%) to estimate future growth. In the same way as with the 10-year 'growth' period, we discount future cash flows to today's value, using a cost of equity of 7.3%.
Terminal Value (TV)= FCF2034 × (1 + g) ÷ (r – g) = ₩780b× (1 + 2.6%) ÷ (7.3%– 2.6%) = ₩17t
Present Value of Terminal Value (PVTV)= TV / (1 + r)10= ₩17t÷ ( 1 + 7.3%)10= ₩8.4t
The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is ₩13t. To get the intrinsic value per share, we divide this by the total number of shares outstanding. Relative to the current share price of ₩150k, the company appears about fair value at a 19% discount to where the stock price trades currently. Remember though, that this is just an approximate valuation, and like any complex formula - garbage in, garbage out.
The Assumptions
The calculation above is very dependent on two assumptions. The first is the discount rate and the other is the cash flows. If you don't agree with these result, have a go at the calculation yourself and play with the assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Amorepacific as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 7.3%, which is based on a levered beta of 1.003. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.
SWOT Analysis for Amorepacific
- Earnings growth over the past year exceeded the industry.
- Debt is not viewed as a risk.
- Dividend is low compared to the top 25% of dividend payers in the Personal Products market.
- Annual revenue is forecast to grow faster than the South Korean market.
- Current share price is below our estimate of fair value.
- Annual earnings are forecast to decline for the next 3 years.
Next Steps:
Whilst important, the DCF calculation is only one of many factors that you need to assess for a company. It's not possible to obtain a foolproof valuation with a DCF model. Preferably you'd apply different cases and assumptions and see how they would impact the company's valuation. If a company grows at a different rate, or if its cost of equity or risk free rate changes sharply, the output can look very different. For Amorepacific, there are three essential elements you should consider:
- Risks: As an example, we've found 3 warning signs for Amorepacific (1 doesn't sit too well with us!) that you need to consider before investing here.
- Future Earnings: How does A090430's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.
- Other High Quality Alternatives: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!
PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the KOSE every day. If you want to find the calculation for other stocks just search here.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About KOSE:A090430
Amorepacific
Researches, develops, manufactures, markets, and sells cosmetics and beauty products worldwide.
Excellent balance sheet and good value.